跳至主要内容
临床试验/NCT06093776
NCT06093776已完成不适用

Rib Fracture Cryoanalgesia

Methodist Health System1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2023年6月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
1
主要终点
Pain Assessment

研究概览

简要总结

Rib fractures lead to poor patient outcomes and even death 3. Data suggests effective pain management is crucial to obtain favorable outcomes 4, 5Current outpatient treatment modalities are limited to oral or topical medications with low efficacy and high risk for opioid dependence. In-patient management with a thoracic epidural TEA is largely considered the gold standard, but the risks of TEA may outweigh the benefits 6 to 8.

详细描述

Methodist Dallas Medical Center MDMC is an urban Level I Trauma Center that manages over 200 rib fracture cases annually. MDMC has a history of developing and using innovative analgesia techniques aimed at improving outcomes. In 2010 we first described the need for advancements in the treatment of rib fracture patients 1. Later, we validated the technique that is now used at hundreds of trauma centers around the world 2. Our surgical and research teams have a history of advocating for optimal management of rib fracture pain in order to prevent serious complications.

This study will seek to describe the effective use of cryoanalgesia as a feasible method of pain management in the rib fracture patient. With a small cohort and case series, we will describe and refine the procedure and preliminary efficacy of the FDA-approved iovera system in adult rib fracture patients. In order to ethically assess the clinical relevance of the iovera system, our objective will be accomplished by completing a case series

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age Acute pain attributed to rib fracture(s) Able to obtain consent

排除标准

  • <18 years of age Pregnant Incarcerated Confounding injuries or significant pain attributed to secondary injury Patients with any of the following: cryoglobulinemia; paroxysmal cold hemoglobinuria; cold urticarial; Raynaud's disease; open and/or infected wounds at or near the treatment site

结局指标

主要结局

Pain Assessment

时间窗: 14 days

Pain assessment using the Numeric Rating Scale for Pain NRS Pain McGill Pain Questionnaire \[MPQ\]), hospital LOS, ICU LOS, ventilator days, pain interference (using the Brief Pain Inventory \[BPI\]), sleep interference (using the Medical Outcomes Sleep Scale \[MOS-Sleep\]), sleep quality (using the Pittsburgh Sleep Quality Index \[PSQI\]), quality of life assessment \[14\], adverse events, re-admissions, and patient satisfaction \[15\].

次要结局

  • Demographics(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验